Literature DB >> 18971619

Clinical and cytogenetic findings on 31,615 mid-trimester amniocenteses.

Sung-Hee Han1, Jeong-Wook An, Gyu-Young Jeong, Hye-Ryoung Yoon, Anna Lee, Young-Ho Yang, Kyu-Pum Lee, Kyoung-Ryul Lee.   

Abstract

BACKGROUND: Since amniocentesis made prenatal diagnosis feasible in 1967, the method has become a popular tool in obstetric practices. In Korea, the demand for genetic counseling and prenatal tests has increased markedly because the number and proportion of pregnancies in women aged 35 yr and older have increased over a 20-yr period. Here we report clinical and cytogenetic findings on 31,615 mid-trimester amniocenteses.
METHODS: To investigate the changes in the annual number of amniocentesis, distribution of indications and age, and cytogenetic findings and abnormality rate according to indications, this study retrospectively analyzed 31,615 cases of mid-trimester amniocentesis performed at Seoul Clinical Laboratories, an independent medical laboratory center, during the past 13 yr (1994-2007).
RESULTS: The annual number of amniocenteses has increased substantially since 1994. Among the 31,615 amniocentesis cases, the maternal age between 30 and 34 yr was the most common age group (35.4%). Among clinical indications, abnormal maternal serum screening results have been the most common indication for amniocentesis since 1994. Chromosomal abnormalities were detected in 973 cases (3.1%). Down syndrome was the most common abnormality found (36.9%, 359/973). In sex chromosomal abnormalities, 53 cases of Turner syndromes, 32 cases of Klinefelter syndromes, 20 cases of triple X syndromes, and 15 cases of 47,XYY were diagnosed. Of structural rearrangements, reciprocal translocations between two autosomes were the most common (15.5%, 151/973). Abnormal ltrasonographic findings showed the highest positive predictive value (5.9%) among the clinical indications.
CONCLUSIONS: The present study could be used for the establishment of a database for genetic counseling. The discovery of an abnormality provides the option of termination or continuation in the pregnancy, a more suitable obstetric management in Korea.

Entities:  

Mesh:

Year:  2008        PMID: 18971619     DOI: 10.3343/kjlm.2008.28.5.378

Source DB:  PubMed          Journal:  Korean J Lab Med        ISSN: 1598-6535


  9 in total

1.  Chromosome abnormalities diagnosed in utero: a Japanese study of 28 983 amniotic fluid specimens collected before 22 weeks gestations.

Authors:  Miyuki Nishiyama; Jim Yan; Junko Yotsumoto; Hideaki Sawai; Akihiko Sekizawa; Yoshimasa Kamei; Haruhiko Sago
Journal:  J Hum Genet       Date:  2015-01-08       Impact factor: 3.172

Review 2.  First trimester ultrasound tests alone or in combination with first trimester serum tests for Down's syndrome screening.

Authors:  S Kate Alldred; Yemisi Takwoingi; Boliang Guo; Mary Pennant; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2017-03-15

Review 3.  First and second trimester serum tests with and without first trimester ultrasound tests for Down's syndrome screening.

Authors:  S Kate Alldred; Yemisi Takwoingi; Boliang Guo; Mary Pennant; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2017-03-15

4.  The importance of rapid aneuploidy screening and prenatal diagnosis in the detection of numerical chromosomal abnormalities.

Authors:  Ghada M Elsayed; Lobna El Assiouty; Ezzat S El Sobky
Journal:  Springerplus       Date:  2013-09-29

5.  Prenatal Diagnosis of Chromosome Abnormalities: A 13-Year Institution Experience.

Authors:  Carmen Comas; Mónica Echevarria; María Ángeles Rodríguez; Ignacio Rodríguez; Bernat Serra; Vincenzo Cirigliano
Journal:  Diagnostics (Basel)       Date:  2012-11-19

Review 6.  First trimester serum tests for Down's syndrome screening.

Authors:  S Kate Alldred; Yemisi Takwoingi; Boliang Guo; Mary Pennant; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2015-11-30

7.  Prediction, prevention and personalisation of medication for the prenatal period: genetic prenatal tests for both rare and common diseases.

Authors:  Munis Dundar; Asli Subasioglu Uzak; Murat Erdogan; Yagut Akbarova
Journal:  EPMA J       Date:  2011-05-06       Impact factor: 6.543

8.  An interesting prenatal diagnosis: double aneuploidy.

Authors:  Cetin Aydin; Serenat Eris; Yakup Yalcin; Halime Sen Selim
Journal:  Case Rep Obstet Gynecol       Date:  2013-12-04

9.  20-year experience on prenatal diagnosis in a reference university medical genetics center in Turkey

Authors:  Burak Durmaz; Hilmi Bolat; Zehra Cengisiz; Fuat Akercan; Tuba Sözen Türk; Erhan Parıltay; Aslı Ece Solmaz; Mert Kazandı; Emin Karaca; Asude Durmaz; Ayça Aykut; Sermet Sağol; Haluk Akın; Ferda Özkınay; ÖzgÜr Çoğulu
Journal:  Turk J Med Sci       Date:  2021-08-30       Impact factor: 0.973

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.